Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pseudomyxoma Peritonei × Tacrolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 63 Myelodysplastic Syndromes 62 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Non-Hodgkin 46 Hodgkin Disease 46 Leukemia 44 Lymphoma 39 Multiple Myeloma 38 Myeloproliferative Disorders 34 Lymphoma, Follicular 34 Graft vs Host Disease 32 Lymphoma, Mantle-Cell 31 Lymphoma, Large B-Cell, Diffuse 31 Leukemia, Myelomonocytic, Chronic 31 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30 Lymphoma, B-Cell, Marginal Zone 29 Burkitt Lymphoma 29 Leukemia, Myeloid, Accelerated Phase 27 Congenital Abnormalities 27 Hematologic Neoplasms 25 Primary Myelofibrosis 23 Leukemia, Myeloid, Chronic-Phase 23 Lymphoma, Large-Cell, Immunoblastic 21 Neoplasms, Plasma Cell 20 Blast Crisis 19 Waldenstrom Macroglobulinemia 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 16 Myelodysplastic-Myeloproliferative Diseases 15

Interventions

Mitomycin 2 Capecitabine 2 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 CTLA-4 Antigen 1 Bromelains 1 Amoxicillin 1 Alemtuzumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06084780 2026-01-23

TRANSCAPE

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡